Sen-Jam Pharmaceutical Announces Upcoming Completion Of SJP-002C Clinical Trial, Offering Hope For A Safe, Potent, And Globally Affordable Treatment For Upper Respiratory Infections And COVID-19

Press/Media

Period22 May 2024

Media coverage

1

Media coverage

  • TitleSen-Jam Pharmaceutical Announces Upcoming Completion Of SJP-002C Clinical Trial, Offering Hope For A Safe, Potent, And Globally Affordable Treatment For Upper Respiratory Infections And COVID-19
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date22/05/24
    PersonsAlex Limkaken
View all 1
View less